Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Abgenix and Diabetogen enter antibody therapy collaboration for autoimmune disease

April 17, 2002

Merckle and Forest reach agreement over ML-3000 in U.S.

April 16, 2002

Vioxx labeling changes and new indication

April 16, 2002

Patent covers Genentech's new alpha4 integrin receptor ligands

April 15, 2002

New series of protein kinase inhibitors prepared at GSK

April 11, 2002

Benzimidazoles and analogues claimed for treatment of inflammatory diseases

April 11, 2002

Xanelim enters phase II trial in moderate to severe rheumatoid arthritis

April 11, 2002

Complement C5a antagonists in the Mitsubishi Pharma pipeline

April 10, 2002

Abbott seeks U.S. and E.U. approval for D2E7 in rheumatoid arthritis

April 10, 2002

Synthesis and evaluation of novel VLA-4 and/or LPAM-1 antagonists reported by Kaken

April 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...